Related references
Note: Only part of the references are listed.Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism
Silvia D'Alessio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA
Danieel Eefting et al.
HUMAN GENE THERAPY (2007)
The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice
Daniel Eefting et al.
ATHEROSCLEROSIS (2007)
Pericellular proteases in angiogenesis and vasculogenesis
VWM van Hinsbergh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery
MS Conte et al.
JOURNAL OF VASCULAR SURGERY (2006)
Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates
AC Newby
CARDIOVASCULAR RESEARCH (2006)
Ex vivo electroporation as a potent new strategy for nonviral gene transfer into autologous vein grafts
T Yamaoka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Extracellular proteases in atherosclerosis and restenosis
A Garcia-Touchard et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
AC Newby
PHYSIOLOGICAL REVIEWS (2005)
Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteries
JF Christiansen et al.
ANNALS OF THORACIC SURGERY (2004)
DNA electrotransfer:: its principles and an updated review of its therapeutic applications
F André et al.
GENE THERAPY (2004)
Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1
MLM Lamfers et al.
CIRCULATION RESEARCH (2002)
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
P Libby et al.
NATURE MEDICINE (2002)
Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions
YH Hu et al.
CIRCULATION RESEARCH (2002)
Accelerated atherosclerosis and calcification in vein grafts -: A study in APOE*3 Leiden transgenic mice
JHP Lardenoye et al.
CIRCULATION RESEARCH (2002)
Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage
JM McMahon et al.
GENE THERAPY (2001)
In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI
MLM Lamfers et al.
GENE THERAPY (2001)
Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels
PHA Quax et al.
CIRCULATION (2001)
Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery
G Pasterkamp et al.
ATHEROSCLEROSIS (2000)
Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
SJ George et al.
CIRCULATION (2000)